Skip to main content

Table 3 Odds ratio (OR) and 95% confidence intervals for abnormal left ventricular geometry according to gender-specific continuous or quartiles of CMI and LAP

From: Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China

Variables Eccentric LVH Concentric LVH
   OR (95% CI)     OR (95% CI)   
  Case (%) Model 1 Model 2 Model 3 Case (%) Model 1 Model 2 Model 3
Females
 CMI (per 1 SD increase)   1.601 (1.482–1.730) 1.453 (1.339–1.576) 1.319 (1.209–1.438)   1.683 (1.500–1.888) 1.527 (1.352–1.723) 1.280 (1.122–1.461)
Quartiles of CMI
 Q1 (≤0.30) 84 (12.2) 1.000 (reference) 1.000 (reference) 1.000 (reference) 26 (9.7) 1.000 (reference) 1.000 (reference) 1.000 (reference)
 Q2 (0.30–0.48) 117 (17.0) 1.491 (1.116–1.992) 1.341 (0.998–1.802) 1.258 (0.934–1.695) 45 (16.8) 1.829 (1.123–2.981) 1.609 (0.983–2.634) 1.451 (0.881–2.389)
 Q3 (0.48–0.83) 222 (32.2) 2.938 (2.261–3.817) 2.407 (1.841–3.146) 2.063 (1.572–2.709) 77 (28.7) 3.083 (1.965–4.837) 2.443 (1.548–3.854) 1.806 (1.135–2.874)
 Q4 (> 0.83) 266 (38.6) 3.736 (2.890–4.829) 2.742 (2.106–3.572) 2.105 (1.600–2.768) 120 (44.8) 5.065 (3.294–7.787) 3.610 (2.330–5.593) 2.236 (1.419–3.522)
P value for trend < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
 LAP (per 1 SD increase)   1.874 (1.716–2.047) 1.668 (1.541–1.849) 1.496 (1.357–1.650)   1.955 (1.713–2.232) 1.742 (1.518–1.998) 1.384 (1.191–1.609)
Quartiles of LAP
 Q1 (≤16.17) 54 (7.9) 1.000 (reference) 1.000 (reference) 1.000 (reference) 20 (7.5) 1.000 (reference) 1.000 (reference) 1.000 (reference)
 Q2 (16.17–28.31) 134 (19.5) 2.587 (1.870–3.579) 2.356 (1.695–3.274) 2.112 (1.515–2.946) 40 (15.0) 1.999 (1.163–3.435) 1.756 (1.017–3.031) 1.395 (0.802–2.427)
 Q3 (28.31–50.95) 199 (29.0) 4.034 (2.959–5.499) 3.329 (2.429–4.563) 2.713 (1.970–3.735) 77 (28.9) 3.949 (2.402–6.492) 3.095 (1.873–5.114) 2.108 (1.263–3.517)
 Q4 (> 50.95) 300 (43.7) 6.580 (4.877–8.879) 4.957 (3.653–6.727) 3.552 (2.587–4.876) 129 (48.5) 6.858 (4.258–11.046) 4.904 (3.206–7.949) 2.544 (1.537–4.209)
P value for trend < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Males
 CMI (per 1 SD increase)   1.264 (1.156–1.383) 1.327 (1.208–1.458) 1.187 (1.075–1.311)   1.309 (1.155–1.483) 1.389 (1.221–1.579) 1.172 (1.019–1.347)
Quartiles of CMI
 Q1 (≤0.27) 85 (17.1) 1.000 (reference) 1.000 (reference) 1.000 (reference) 39 (16.7) 1.000 (reference) 1.000 (reference) 1.000 (reference)
 Q2 (0.27–0.46) 108 (21.8) 1.219 (0.908–1.638) 1.167 (0.865–1.575) 1.158 (0.855–1.567) 55 (23.6) 1.348 (0.888–2.047) 1.356 (0.890–2.065) 1.270 (0.826–1.954)
 Q3 (0.46–0.82) 138 (27.8) 1.719 (1.296–2.280) 1.722 (1.292–2.295) 1.553 (1.160–2.080) 58 (24.9) 1.527 (1.010–2.309) 1.613 (1.063–2.448) 1.300 (0.846–1.997)
 Q4 (> 0.82) 165 (33.3) 2.018 (1.534–2.654) 2.216 (1.672–2.935) 1.724 (1.287–2.311) 81 (34.8) 2.089 (1.414–3.085) 2.395 (1.611–3.562) 1.523 (1.003–2.313)
P value for trend < 0.001 < 0.001 < 0.001 < 0.001 0.001 < 0.001 < 0.001 0.057
 LAP (per 1 SD increase)   1.353 (1.228–1.490) 1.437 (1.297–1.591) 1.251 (1.123–1.394)   1.461 (1.273–1.677) 1.559 (1.351–1.793) 1.233 (1.056–1.441)
Quartiles of LAP
 Q1 (≤10.71) 77 (15.6) 1.000 (reference) 1.000 (reference) 1.000 (reference) 43 (18.5) 1.000 (reference) 1.000 (reference) 1.000 (reference)
 Q2 (10.71–21.85) 98 (19.9) 1.242 (0.912–1.692) 1.200 (0.877–1.642) 1.092 (0.795–1.499) 41 (17.6) 0.914 (0.591–1.412) 0.900 (0.581–1.395) 0.711 (0.454–1.113)
 Q3 (21.85–43.60) 153 (31.0) 2.031 (1.526–2.702) 2.035 (1.521–2.723) 1.682 (1.250–2.264) 60 (25.8) 1.357 (0.910–2.023) 1.396 (0.933–2.090) 0.940 (0.619–1.427)
 Q4 (> 43.60) 165 (33.5) 2.215 (1.670–2.938) 2.489 (1.864–3.324) 1.768 (1.305–2.396) 89 (38.2) 2.063 (1.421–2.995) 2.345 (1.606–3.423) 1.234 (0.824–1.849)
P value for trend < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.091
  1. Model 1: unadjusted; Model 2: adjusted for age, race, education level, family income, diet score, current smoking and drinking status, physical activity; Model 3: adjusted for all the factors in Model 2 and hypertension, diabetes, antihypertensive drug, and antidiabetic drug, lipid-lowering drug, and history of cardiovascular disease (coronary heart disease, arrhythmia and heart failure). Abbreviations: OR odd ratio; 95% CI 95% confidence interval, CMI cardiometabolic index, LAP lipid accumulation product, LVH left ventricular hypertrophy